0001127602-21-015189.txt : 20210504
0001127602-21-015189.hdr.sgml : 20210504
20210504161715
ACCESSION NUMBER: 0001127602-21-015189
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210503
FILED AS OF DATE: 20210504
DATE AS OF CHANGE: 20210504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jackson Blair Curtis
CENTRAL INDEX KEY: 0001842348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 21888699
MAIL ADDRESS:
STREET 1: 852 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-05-03
0001520262
Alkermes plc.
ALKS
0001842348
Jackson Blair Curtis
852 WINTER ST.
WALTHAM
MA
02451
1
EVP, Chief Operating Officer
Ordinary Shares
2021-05-03
4
M
0
34503
18.105
A
102657
D
Ordinary Shares
2021-05-03
4
S
0
34503
22.1765
D
68154
D
Employee Stock Option (Right to Buy)
18.105
2021-05-03
4
M
0
34503
0
D
2021-05-20
Ordinary Shares
34503
0
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.55. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
These options are fully vested in accordance with their terms.
/s/ Shantale Greenson, attorney-in-fact for Blair C. Jackson
2021-05-04